𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is methotrexate oncogenic in patientswith rheumatoid arthritis?

✍ Scribed by Joel M. Kremer


Book ID
114098580
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
228 KB
Volume
26
Category
Article
ISSN
0049-0172

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Methotrexate in rheumatoid arthritis
✍ Daniel E. Furst; Joel M. Kremer πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 1007 KB

Methotrexate (MTX) is effective in the treatment of refractory rheumatoid arthritis (RA). Its use by practitioners has become commonplace, even though it is not yet approved by the Food and Drug Administration for this use. One might assume, therefore, that there is a general understanding, among pr

Methotrexate in rheumatoid arthritis
✍ Weinblatt, Michael E.; Kremer, Joel M. πŸ“‚ Article πŸ“… 1988 πŸ› Elsevier Science 🌐 English βš– 301 KB
Methotrexate in Rheumatoid Arthritis
✍ Tugwell, Peter πŸ“‚ Article πŸ“… 1990 πŸ› American Medical Association 🌐 English βš– 579 KB
Methotrexate in refractory rheumatoid ar
✍ A. M. Th. Boerbooms; M. E. C. Jeurissen; A. A. A. Westgeest; H. Theunisse; L. B. πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 494 KB
Methotrexate in juvenile rheumatoid arth
✍ F. Albertioni; O. Beck; C. Peterson; B. FlatΓΈ; O. Vinje; S. Eksborg; P. Seideman πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 490 KB

Children with juvenile rheumatoid arthritis (JRA) have been reported to require higher doses (per kg body weight) of methotrexate (MTX) than adults with rheumatoid arthritis to control their disease. The purpose of the present study was to characterise the plasma pharmacokinetics of MTX and its majo